Marian McDonagh, PharmD, Principal Investigator, Drug Effectiveness Review Project
Washington State Preferred Drug Program selected the topic, had input into the Key Questions, and funded this review. The content and conclusions of the review are entirely determined by the Evidence-based Practice Center researchers. The authors of this report have no financial interest in any company that makes or distributes the products reviewed in this report.
Selover D, Dana T, Smith C, Peterson, K. Drug class review on nasal corticosteroids. Update #1 final report. 2008.
The Agency for Healthcare Research and Quality has not yet seen or approved this report.
The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports.